Clinical trial for Intracerebral Hemorrhage
Official title International Care Bundle Evaluation in Cerebral Hemorrhage Research
ClinicalTrials.gov ID: NCT06429332
What this study is testing
- What it's testing
- The study aims to find out whether a set of early treatments (lowering blood pressure, controlling fever and blood sugar) leads to better 3‑month outcomes compared with usual care.
- Who it's for
- Adults who have a spontaneous intracerebral hemorrhage (a type of stroke caused by bleeding in the brain).
- What's involved
- Participants will receive the care bundle, early intensive blood‑pressure lowering, fever treatment, and blood‑sugar control, plus any standard care, with scheduled check‑ups and tests.
- Time commitment
- The study follows participants for about three months, requiring hospital visits and assessments during that period.
- Phase 4: studies an already-approved treatment
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults (age ≥18 years)
- Non-contrast computerized tomography (NCCT) imaging-verified diagnosis of spontaneous intracerebral haemorrhage
- ≤24 hours from symptom onset or presumed symptom onset (last seen well)
You likely can't join if
- Previous care limitation
- End-stage comorbidity with short life-expectancy (\<6 m; e.g. terminal cancer)
- ICH caused by brain tumor or cerebral venous thrombosis
- Clinical signs of brain herniation at first presentation (unresponsive patient with bilaterally fixed, maximally dilated pupils)
- Pregnant women beyond 22 weeks gestation may only be included after thorough discussion with an obstetrician to determine risks vs benefit.
The study team makes the final eligibility decision.
Where it is enrolling
- Oklahoma City, Oklahoma, United States
- Adelaide, Australia
- Clayton, Australia
- Greater Sudbury, Ontario, Canada
- Hamilton, Ontario, Canada
- Ottawa, Ontario, Canada
- Hong Kong, Hong Kong
- Reykjavik, Iceland
- Avezzano, Italy
- Città di Castello, Italy
- Gubbio, Italy
- Perugia, Italy
- Roma, Italy
- Kuala Lumpur, Malaysia
- Serdang, Malaysia
- Eksjö, Sweden
- Gothenburg, Sweden
- Hässleholm, Sweden
- Helsingborg, Sweden
- Huddinge, Sweden
+ 26 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Oklahoma City, Oklahoma, United States; Adelaide, Australia; Clayton, Australia; Greater Sudbury, Ontario, Canada; Hamilton, Ontario, Canada; Ottawa, Ontario, Canada and 40 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.